HFCAS OpenIR  > 中科院强磁场科学中心
Discovery of 4-Methyl-N-(44(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-y1)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding
Wang, Qiang1,2; Liu, Feiyang1,3; Wang, Beilei1,3; Zou, Fengming1,2; Qi, Ziping1,2; Chen, Cheng1,3; Yu, Kailin1,3; Hu, Chen1,3; Qi, Shuang1,2; Wang, Wenchao1,2; Hu, Zhenquan1,2; Liu, Juan1; Wang, Wei1,2; Wang, Li1,3; Liang, Qianmao1; Zhang, Shanchun2,4; Ren, Tao5; Liu, Qingsong1,2,3,5; Liu, Jing1,2
2017-01-12
Source PublicationJOURNAL OF MEDICINAL CHEMISTRY
Volume60Issue:1Pages:273-289
AbstractThe discovery of a novel potent type II ABL/c-KIT dual kinase inhibitor compound. 34 (CHMFL-ABL/KIT-155), which utilized a hydrogen bond formed by NH on the kinase backbone and carbonyl oxygen of 34 as a unique hinge binding, is described. 34 potently inhibited purified ABL (IC50: 46 nM) and c-KIT kinase (IC50: 75 nM) in the biochemical assays and displayed high selectivity (S Score (1) = 0.03) at the concentration of 1 mu M among 468 kinases/mutants in KINOMEscan assay. It exhibited strong antiproliferative activities against BCR-ABL/c-KIT driven CML/GISTs cancer cell lines through blockage of the BCR-ABL/c-KIT mediated signaling pathways, arresting cell cycle progression and induction of apoptosis. 34 possessed a good oral PK property and effectively suppressed the tumor progression in the K562 (CML) and GIST-T1 (GISTs) cells mediated xenograft mouse model. The distinct hinge-binding mode of 34 provided a novel pharmacophore for expanding the chemical structure diversity for the type II kinase inhibitors discovery.
SubtypeArticle
WOS HeadingsScience & Technology ; Life Sciences & Biomedicine
Funding OrganizationJoint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973)
DOI10.1021/acs.jmedchem.6b01290
WOS KeywordSTRUCTURAL MECHANISM ; TYROSINE KINASE ; BCR-ABL ; RECEPTOR ; MODE ; MET
Indexed BySCI
Language英语
Funding OrganizationJoint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC(U1432250) ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; CAS/SAFEA international partnership program for creative research teams ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; "Personalized Medicines-Molecular Signature-Based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12020308) ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; National Program for Support of Topnotch Young Professionals ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; "Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation" of Chinese Academy of Sciences ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; China "Thousand Talents Program" ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; "Hundred Talents Program" of the Chinese Academy of Sciences ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973) ; National Natural Science Foundation of China(81602973)
WOS Research AreaPharmacology & Pharmacy
WOS SubjectChemistry, Medicinal
WOS IDWOS:000392035100018
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.hfcas.ac.cn:8080/handle/334002/32787
Collection中科院强磁场科学中心
Affiliation1.Chinese Acad Sci, High Field Magnet Lab, Mailbox 1110,350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China
2.CHMFL HCMTC Target Therapy Joint Lab, 350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China
3.Univ Sci & Technol China, Hefei 230036, Anhui, Peoples R China
4.Hefei Cosource Med Technol Co Ltd, 358 Ganquan Rd, Hefei 230031, Anhui, Peoples R China
5.Chinese Acad Sci, Hefei Inst Phys Sci, Inst Technol Innovat, Precis Targeted Therapy Discovery Ctr, Hefei 230088, Anhui, Peoples R China
First Author AffilicationChinese Acad Sci, High Field Magnet Lab,Hefei 230031, Anhui, Peoples R China
Recommended Citation
GB/T 7714
Wang, Qiang,Liu, Feiyang,Wang, Beilei,et al. Discovery of 4-Methyl-N-(44(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-y1)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding[J]. JOURNAL OF MEDICINAL CHEMISTRY,2017,60(1):273-289.
APA Wang, Qiang.,Liu, Feiyang.,Wang, Beilei.,Zou, Fengming.,Qi, Ziping.,...&Liu, Jing.(2017).Discovery of 4-Methyl-N-(44(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-y1)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding.JOURNAL OF MEDICINAL CHEMISTRY,60(1),273-289.
MLA Wang, Qiang,et al."Discovery of 4-Methyl-N-(44(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-y1)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding".JOURNAL OF MEDICINAL CHEMISTRY 60.1(2017):273-289.
Files in This Item: Download All
File Name/Size DocType Version Access License
Discovery of 4-Methy(3516KB)期刊论文作者接受稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wang, Qiang]'s Articles
[Liu, Feiyang]'s Articles
[Wang, Beilei]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wang, Qiang]'s Articles
[Liu, Feiyang]'s Articles
[Wang, Beilei]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang, Qiang]'s Articles
[Liu, Feiyang]'s Articles
[Wang, Beilei]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Discovery of 4-Methyl-N-(44(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-y1)oxy)benzamide (CHMFL-ABL_KIT-155) .pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.